RC
Rubric Capital Management LP
Rubric Capital Management LP · Investor
1Y performance ⓘ
+22%
AUM (13F)
$9.4B
# of Holdings
81
3Y performance ⓘ
+75%
vs S&P 500 ⓘ
−4%
Updated
Mar 31
Rubric Capital Management LP's Rubric Capital Management LP holds 81 U.S.-equity positions worth $9.4B (SEC 13F, Q1 2026). Top positions: Ishares Tr 13.5%, Talen Energy Corporation Common Stock 12.2%, FTAI Aviation Ltd. Common Stock 6.7%. 13F-replication return is +75% over 3 years (-4 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| IWM Ishares Tr | 13.5% | 5.2M | $1.3B | NEW (+5.2M) | $232.61 | $277.15 (+19%) | 2026-03-31 |
| TLN Talen Energy Corporation Common Stock | 12.2% | 3.6M | $1.1B | — | $178.24 | $327.66 (+84%) | 2026-03-31 |
| FTAI FTAI Aviation Ltd. Common Stock | 6.7% | 2.6M | $631M | ▼ 30% (−1.1M) | $119.71 | $167.03 (+40%) | 2026-03-31 |
| GLNG Golar LNG Ltd | 5.3% | 9.2M | $497M | — | $26.15 | $47.10 (+80%) | 2026-03-31 |
| TEVA Teva Pharmaceutical Inds Ltd | 4.9% | 15.2M | $459M | ▼ 29% (−6.1M) | $11.04 | $39.24 (+255%) | 2026-03-31 |
| VTRS Viatris Inc. Common Stock | 4.8% | 33.5M | $453M | ▲ 31% (+8.0M) | $11.67 | $17.77 (+52%) | 2026-03-31 |
| TAC TransAlta Corporation | 2.5% | 17.8M | $233M | — | $10.42 | $12.15 (+17%) | 2026-03-31 |
| BGC BGC Group, Inc. Class A Common Stock | 2.4% | 23.3M | $228M | ▲ 11% (+2.3M) | $6.41 | $11.44 (+78%) | 2026-03-31 |
| VST Vistra Corp. | 2.4% | 1.5M | $225M | ▼ 25% (−500K) | $128.76 | $141.01 (+10%) | 2026-03-31 |
| CEG Constellation Energy Corporation Common Stock | 2.1% | 715K | $200M | ▲ 6.7% (+45K) | $346.29 | $268.56 (−22%) | 2026-03-31 |
| ARQT Arcutis Biotherapeutics, Inc. Common Stock | 2.1% | 8.3M | $195M | — | $8.97 | $26.32 (+193%) | 2026-03-31 |
| MCY Mercury General Corp. | 2.0% | 2.2M | $190M | ▲ 4.9% (+100K) | $58.63 | $99.60 (+70%) | 2026-03-31 |
| KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | 1.9% | 3.8M | $181M | ▲ 13% (+421K) | $24.09 | $74.47 (+209%) | 2026-03-31 |
| ZYME Zymeworks Inc. | 1.9% | 7.0M | $175M | ▲ 22% (+1.2M) | $14.84 | $26.32 (+77%) | 2026-03-31 |
| AKAM Akamai Technologies Inc | 1.6% | 1.3M | $149M | ▲ 8.3% (+100K) | $89.37 | $105.95 (+19%) | 2026-03-31 |
| LBTYA Liberty Global Ltd. Class A Common Shares | 1.5% | 11.8M | $142M | ▲ 17% (+1.7M) | $14.06 | $9.12 (−35%) | 2026-03-31 |
| ROIV Roivant Sciences Ltd. Common Shares | 1.5% | 5.0M | $138M | ▼ 44% (−4.0M) | $10.74 | $36.58 (+241%) | 2026-03-31 |
| AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock | 1.4% | 11.0M | $137M | ▼ 11% (−1.3M) | $5.62 | $20.18 (+259%) | 2026-03-31 |
| LILAK Liberty Latin America Ltd. Class C Common Stock | 1.4% | 15.4M | $136M | ▲ 44% (+4.7M) | $7.76 | $8.31 (+7%) | 2026-03-31 |
| DK Delek US Holdings, Inc. | 1.3% | 2.7M | $121M | — | $18.57 | $71.17 (+283%) | 2026-03-31 |
| CMPR Cimpress PLC Ordinary Shares (Ireland) | 1.3% | 1.6M | $119M | ▲ 6.8% (+104K) | $57.81 | $78.71 (+36%) | 2026-03-31 |
| ECVT Ecovyst Inc. | 1.2% | 9.1M | $117M | ▼ 13% (−1.4M) | $8.53 | $9.62 (+13%) | 2026-03-31 |
| LBTYK Liberty Global Ltd. Class C Common Shares | 1.1% | 9.3M | $109M | ▲ 51% (+3.1M) | $13.80 | $8.87 (−36%) | 2026-03-31 |
| ADEA Adeia Inc. Common Stock | 1.1% | 4.3M | $103M | — | $8.88 | $25.49 (+187%) | 2026-03-31 |
| EPC Edgewell Personal Care Company | 0.9% | 4.0M | $85M | ▲ 297% (+3.0M) | $20.26 | $26.74 (+32%) | 2026-03-31 |
| ZM Zoom Communications, Inc. Class A Common Stock | 0.8% | 1.0M | $80M | NEW (+1.0M) | $80.39 | $90.69 (+13%) | 2026-03-31 |
| TDS Telephone and Data Systems Inc. | 0.8% | 1.9M | $78M | — | $39.48 | $34.34 (−13%) | 2026-03-31 |
| GIL Gildan Activewear Inc. | 0.8% | 1.4M | $78M | ▲ 444% (+1.1M) | $56.62 | $42.61 (−25%) | 2026-03-31 |
| IART Integra LifeSciences Holdings | 0.8% | 7.8M | $73M | — | $18.24 | $16.32 (−11%) | 2026-03-31 |
| SDGR Schrodinger, Inc. Common Stock | 0.7% | 6.0M | $68M | ▲ 44% (+1.8M) | $17.77 | $31.40 (+77%) | 2026-03-31 |
| SPRY ARS Pharmaceuticals, Inc. Common Stock | 0.7% | 8.0M | $64M | ▲ 29% (+1.8M) | $10.02 | $4.37 (−56%) | 2026-03-31 |
| GEO The GEO Group, Inc. | 0.7% | 3.7M | $63M | ▲ 7.3% (+256K) | $21.76 | $30.54 (+40%) | 2026-03-31 |
| SSYS Stratasys Inc (ISRAEL) | 0.7% | 8.0M | $62M | ▲ 9.0% (+660K) | $12.02 | $8.30 (−31%) | 2026-03-31 |
| ANDE Andersons Inc/The | 0.7% | 856K | $61M | ▼ 15% (−150K) | $53.17 | $65.13 (+22%) | 2026-03-31 |
| MGTX MeiraGTx Holdings plc Ordinary Shares | 0.6% | 7.0M | $61M | ▲ 13% (+825K) | $7.34 | $11.00 (+50%) | 2026-03-31 |
| ENOV Enovis Corporation | 0.6% | 2.5M | $56M | — | $30.34 | $18.34 (−40%) | 2026-03-31 |
| OPK Opko Health Inc. | 0.6% | 47.8M | $54M | — | $1.27 | $1.60 (+26%) | 2026-03-31 |
| QDEL QuidelOrtho Corporation Common Stock | 0.6% | 3.3M | $54M | ▼ 12% (−471K) | $46.83 | $10.35 (−78%) | 2026-03-31 |
| PRMB Primo Brands Corporation | 0.6% | 2.8M | $52M | ▼ 23% (−846K) | $16.35 | $19.02 (+16%) | 2026-03-31 |
| NWL Newell Brands Inc. | 0.6% | 15.3M | $52M | ▲ 17% (+2.3M) | $4.97 | $5.24 (+5%) | 2026-03-31 |
| AMCR Amcor plc Ordinary Shares | 0.5% | 1.3M | $50M | NEW (+1.3M) | $39.75 | $41.44 (+4%) | 2026-03-31 |
| RNW ReNew Energy Global plc Class A Ordinary Shares | 0.5% | 11.0M | $50M | — | $5.86 | $6.84 (+17%) | 2026-03-31 |
| PRTA Prothena Corporation plc Ordinary Shares | 0.5% | 5.0M | $49M | ▲ 36% (+1.3M) | $9.66 | $8.52 (−12%) | 2026-03-31 |
| PTGX Protagonist Therapeutics, Inc | 0.5% | 428K | $45M | NEW (+428K) | $70.01 | $140.09 (+100%) | 2026-03-31 |
| TRVI Trevi Therapeutics, Inc. Common Stock | 0.5% | 3.7M | $44M | ▼ 1.4% (−54K) | $3.72 | $14.38 (+287%) | 2026-03-31 |
| OFIX Orthofix Medical Inc. Common Stock (DE) | 0.5% | 3.7M | $43M | — | $15.51 | $9.43 (−39%) | 2026-03-31 |
| COLL Collegium Pharmaceutical, Inc. Common Stock | 0.5% | 1.3M | $42M | ▼ 14% (−217K) | $27.76 | $21.95 (−21%) | 2026-03-31 |
| CXW CoreCivic, Inc. | 0.4% | 2.1M | $39M | ▲ 5.0% (+98K) | $20.42 | $32.28 (+58%) | 2026-03-31 |
| NRIX Nurix Therapeutics, Inc. Common stock | 0.4% | 2.5M | $38M | — | $18.97 | $23.77 (+25%) | 2026-03-31 |
| DRVN Driven Brands Holdings Inc. Common Stock | 0.4% | 3.0M | $38M | NEW (+3.0M) | $12.61 | $11.74 (−7%) | 2026-03-31 |
Showing top 50 of 81 holdings by value.
FAQ ▾
What are Rubric Capital Management LP's largest holdings?
As of the latest 13F: Ishares Tr 13.5%, Talen Energy Corporation Common Stock 12.2%, FTAI Aviation Ltd. Common Stock 6.7%, Golar LNG Ltd 5.3%, Teva Pharmaceutical Inds Ltd 4.9%.
How big is Rubric Capital Management LP's 13F portfolio?
$9.4B across 81 disclosed U.S.-equity positions.
What is Rubric Capital Management LP's 3-year performance?
+75% (13F-replication, price return), -4 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.